SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Drew Ann Elena

(Last)

(First)

(Middle)

C/O WEX INC.

97 DARLING AVENUE

(Street)

SOUTH PORTLAND

04106

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/02/2020

3. Issuer Name and Ticker or Trading Symbol
WEX Inc. [ WEX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Risk and Compliance

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,597	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽¹⁾	⁽¹⁾	Common Stock	304	$0.0	D
Restricted Stock Units	⁽²⁾	⁽²⁾	Common Stock	53	$0.0	D
Restricted Stock Units	⁽³⁾	⁽³⁾	Common Stock	109	$0.0	D
Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common Stock	741	$0.0	D
Restricted Stock Units	⁽⁵⁾	⁽⁵⁾	Common Stock	1,954	$0.0	D
Restricted Stock Units	⁽⁶⁾	⁽⁶⁾	Common Stock	206	$0.0	D
Restricted Stock Units	⁽⁷⁾	⁽⁷⁾	Common Stock	593	$0.0	D
Restricted Stock Units	⁽⁸⁾	⁽⁸⁾	Common Stock	313	$0.0	D
Stock Option (right to buy)	03/15/2016⁽⁹⁾	03/15/2025	Common Stock	87	$103.75	D
Stock Option (right to buy)	03/15/2017⁽¹⁰⁾	03/15/2026	Common Stock	382	$77.2	D
Stock Option (right to buy)	03/20/2018⁽¹¹⁾	03/20/2027	Common Stock	421	$104.95	D
Stock Option (right to buy)	03/15/2019⁽¹²⁾	03/15/2018	Common Stock	487	$158.23	D
Stock Option (right to buy)	03/20/2020⁽¹³⁾	03/20/2029	Common Stock	515	$184.81	D
Stock Option (right to buy)	03/16/2021⁽¹⁴⁾	03/16/2030	Common Stock	1,139	$109.66	D

Explanation of Responses:

1. RSUs vest with respect to the entirety of these units on December 15, 2020.

2. RSUs vest with respect to the entirety of these units on March 15, 2021.

3. RSUs vest with respect to half of these units on March 20, 2021 and March 20, 2022.

4. RSUs vest with respect to the entirety of these units on June 17, 2022.

5. RSUs vest with respect to the entirety of these units on December 16, 2022.

6. RSUs vest with respect to half of these units on March 16, 2021 and March 16, 2022.

7. RSUs vest with respect one third of these units on March 16, 2021, March 16, 2022, and March 16, 2023.

8. RSUs vest with respect to half of these units on June 24, 2022 and June 24, 2023.

9. This option became exercisable with respect to 29 units on March 15, 2016, 29 units on March 15, 2017, and 29 units on March 15, 2018.

10. This option became exercisable with respect to 127 shares on March 15, 2017, 127 shares on March 15, 2018, and 128 shares on March 15, 2019.

11. This option became exercisable with respect to 140 shares on March 20, 2018, 140 shares on March 20, 2019, and 141 shares on March 20, 2020.

12. This option became exercisable with respect to 162 units on March 15, 2019 and 162 units on March 15, 2020, and becomes exercisable with respect to 163 shares on March 15, 2021.

13. This option became exercisable with respect to 171 shares on March 20, 2020, and becomes exercisable with respect to 171 shares on March 20, 2021 and 173 shares on March 20, 2022.

14. This option becomes exercisable with respect to 379 shares on March 16, 2021, 379 shares on March 16, 2022, and 381 shares on March 16, 2023.

Remarks:

EXHIBIT LIST: EX-24 Power of Attorney Ann Drew

	/s/ Gregory Wiessner, as attorney-in-fact for Ann Elena Drew	12/14/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.